Haemonetics officer proposes $101K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Haemonetics Corp officer Maryanne Farris reported a proposed sale of 836 common shares, with an aggregate market value of $101,144.38 and an approximate sale date of November 11, 2026. The securities table lists three restricted-stock vesting acquisitions and one stock option exercise among the acquisition transactions for securities identified for sale.
Key Figures
Key Terms
Restricted Stock Vesting financial
Stock Option Exercise financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.